期刊文献+

Effect of the platelet membrane GPⅠa gene polymorphism in the pathogenesis of unstable angina pectoris

Effect of the platelet membrane GPⅠa gene polymorphism in the pathogenesis of unstable angina pectoris
下载PDF
导出
摘要 Objective: To investigate the effect of platelet membrane glycoprotein(GP) Ⅰa gene polymorphism in the pathogenesis of unstable angina pectoris (UAP) in Chinese people. Methods: Collagen type Ⅰ-induced platelet aggregation was measured in 33 healthy subjects in vitro. Plasma level of α-granule membrane protein (GMP-140) was measured in both the above 33 healthy subjects during fasting and 35 patients with recent onset effort anina during rest onset within 24 h after hospitalization. Furthermore, the platelet membrane GP Ⅰa gene 807C/T polymorphism was checked in all subjects with polymerase chain reaction-sequence specific primers(PCR-SSP) technique. Results: The lag time before 30% platelet aggregation was significantly longer in healthy subjects with CC genotype than with TC genotype (P<0.01). However, there was no significant difference in the maximal platelet aggregation between healthy subjects with the above two genotypes. Plasma level of GMP-140 was significantly higher in TC genotypic patients with recent onset effort angina than in CC genotypic patients with the same type of UAP(P<0.05) and healthy subjects (P<0.01), furthermore, there was also significant difference between the latter two groups(P<0.05). Conclusion: The rapid initiation of collagen-induced platelet aggregation may be associated with platelet membrane GP Ⅰa T (807) allele, which may play an important role in the pathogenesis of UAP. Objective: To investigate the effect of platelet membrane glycoprotein(GP) Ⅰa gene polymorphism in the pathogenesis of unstable angina pectoris (UAP) in Chinese people. Methods: Collagen type Ⅰ-induced platelet aggregation was measured in 33 healthy subjects in vitro. Plasma level of α-granule membrane protein (GMP-140) was measured in both the above 33 healthy subjects during fasting and 35 patients with recent onset effort anina during rest onset within 24 h after hospitalization. Furthermore, the platelet membrane GP Ⅰa gene 807C/T polymorphism was checked in all subjects with polymerase chain reaction-sequence specific primers(PCR-SSP) technique. Results: The lag time before 30% platelet aggregation was significantly longer in healthy subjects with CC genotype than with TC genotype (P<0.01). However, there was no significant difference in the maximal platelet aggregation between healthy subjects with the above two genotypes. Plasma level of GMP-140 was significantly higher in TC genotypic patients with recent onset effort angina than in CC genotypic patients with the same type of UAP(P<0.05) and healthy subjects (P<0.01), furthermore, there was also significant difference between the latter two groups(P<0.05). Conclusion: The rapid initiation of collagen-induced platelet aggregation may be associated with platelet membrane GP Ⅰa T (807) allele, which may play an important role in the pathogenesis of UAP.
出处 《Journal of Nanjing Medical University》 2005年第3期126-130,共5页 南京医科大学学报(英文版)
关键词 PLATELET GLYCOPROTEIN POLYMORPHISM angina pectoris platelet glycoprotein polymorphism angina pectoris
  • 相关文献

参考文献1

二级参考文献10

  • 1Tooke J, Hannemann M. Adverse endothelial function and insulin resistance syndrome [J]. J Int Med, 2000, 247:425 - 431.
  • 2Sartori MT, Vettor R, De Pergola G, et al. Role of the 4G/5G polymorphism of PAI-1 gene promoter on PAI-1levels in obese patients-Influence of fat distribution and insulin-resistance [J]. Thromb Haemost, 2001, 86(5):1161 - 1169.
  • 3Brown NJ, Abbas A, Byrne D, et al. Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women[J]. Circulation, 2002, 105:304 -309.
  • 4Ye S, Green FR, Scarabin PY, et al. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1(PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study[J] . Thromb Haemost, 1995,74:837 - 841.
  • 5Song J, Yoon YM, Jung HJ, et al. Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor Ⅶ Arg353→Gln polymorphism in Korean patients with coronary artery disease[J]. J Korean Med Sci, 2000,15:146 - 152.
  • 6Nordt TK, Lohrmann J, Bode C. Regulation of PAI-1 expression by genetic polymorphisms-Impact on atherogenesis [J]. Thromb Research, 2001, 103(Suppl 1): S1 -S5.
  • 7Segui R, Estelles A, Mira Y, et al. PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects [J]. Bri J Haema, 2000, 111:122 - 128.
  • 8Mansfield MW, Stickland MH, Grant PJ. Plasminogen activator inhibitor-1(PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes mellitus[J]. Thromb Haemost, 1995, 74: 1032- 1034.
  • 9HindorffLA, Schwartz SM , SiscovickDS, etal. Theassociation of PAI- 1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke inyoung women [J]. J Cardiovascular Risk, 2002, 9(2):131 - 137.
  • 10Groop L, Melander M. The dysmetabolic syndrome[J]. J Int Med, 2001, 250:105 - 120.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部